These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 23537503)
1. Nanocarrier systems for oral drug delivery: do we really need them? Bernkop-Schnürch A Eur J Pharm Sci; 2013 May; 49(2):272-7. PubMed ID: 23537503 [TBL] [Abstract][Full Text] [Related]
2. Reprint of: Nanocarrier systems for oral drug delivery: do we really need them? Bernkop-Schnürch A Eur J Pharm Sci; 2013 Sep; 50(1):2-7. PubMed ID: 23816602 [TBL] [Abstract][Full Text] [Related]
3. Nanocarriers for oral drug delivery. Zhang L; Wang S; Zhang M; Sun J J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127 [TBL] [Abstract][Full Text] [Related]
5. Hydrophobic ion-pairs and lipid-based nanocarrier systems: The perfect match for delivery of BCS class 3 drugs. Phan TNQ; Shahzadi I; Bernkop-Schnürch A J Control Release; 2019 Jun; 304():146-155. PubMed ID: 31075345 [TBL] [Abstract][Full Text] [Related]
6. Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication. Shahbazi MA; Santos HA Curr Drug Metab; 2013 Jan; 14(1):28-56. PubMed ID: 22497568 [TBL] [Abstract][Full Text] [Related]
15. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Hunter AC; Elsom J; Wibroe PP; Moghimi SM Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372 [TBL] [Abstract][Full Text] [Related]
16. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. Date AA; Hanes J; Ensign LM J Control Release; 2016 Oct; 240():504-526. PubMed ID: 27292178 [TBL] [Abstract][Full Text] [Related]
17. Thiomers for oral delivery of hydrophilic macromolecular drugs. Bernkop-Schnürch A; Hoffer MH; Kafedjiiski K Expert Opin Drug Deliv; 2004 Nov; 1(1):87-98. PubMed ID: 16296722 [TBL] [Abstract][Full Text] [Related]
18. Improvement of drug safety by the use of lipid-based nanocarriers. Lim SB; Banerjee A; Önyüksel H J Control Release; 2012 Oct; 163(1):34-45. PubMed ID: 22698939 [TBL] [Abstract][Full Text] [Related]
19. Strategies for improving mucosal drug delivery. Laffleur F; Bernkop-Schnürch A Nanomedicine (Lond); 2013 Dec; 8(12):2061-75. PubMed ID: 24279493 [TBL] [Abstract][Full Text] [Related]
20. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers. Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]